110 related articles for article (PubMed ID: 33392837)
1. Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature.
Huang CS; Lu TP; Liu CY; Huang CJ; Chiu JH; Chen YJ; Tseng LM; Huang CC
Breast Cancer Res Treat; 2021 Apr; 186(2):475-485. PubMed ID: 33392837
[TBL] [Abstract][Full Text] [Related]
2. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.
Low YS; Blöcker C; McPherson JR; Tang SA; Cheng YY; Wong JYS; Chua C; Lim TKH; Tang CL; Chew MH; Tan P; Tan IB; Rozen SG; Cheah PY
Cancer Lett; 2017 Sep; 403():13-20. PubMed ID: 28624625
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classification.
Kojima K; April C; Canasto-Chibuque C; Chen X; Deshmukh M; Venkatesh A; Tan PS; Kobayashi M; Kumada H; Fan JB; Hoshida Y
PLoS One; 2014; 9(1):e86961. PubMed ID: 24498002
[TBL] [Abstract][Full Text] [Related]
5. Concurrent gene signatures for han chinese breast cancers.
Huang CC; Tu SH; Lien HH; Jeng JY; Huang CS; Huang CJ; Lai LC; Chuang EY
PLoS One; 2013; 8(10):e76421. PubMed ID: 24098497
[TBL] [Abstract][Full Text] [Related]
6. A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
Park YH; Jung HH; Do IG; Cho EY; Sohn I; Jung SH; Kil WH; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH
Int J Cancer; 2015 Apr; 136(8):1976-84. PubMed ID: 25537444
[TBL] [Abstract][Full Text] [Related]
7. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer concurrent gene signature based on coherent patterns between genomic and transcriptional alterations.
Shen MH; Huang CJ; Ho TF; Liu CY; Shih YY; Huang CS; Huang CC
BMC Cancer; 2022 May; 22(1):590. PubMed ID: 35637462
[TBL] [Abstract][Full Text] [Related]
9. An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer.
Sánchez-Navarro I; Gámez-Pozo A; Pinto A; Hardisson D; Madero R; López R; San José B; Zamora P; Redondo A; Feliu J; Cejas P; González Barón M; Angel Fresno Vara J; Espinosa E
BMC Cancer; 2010 Jun; 10():336. PubMed ID: 20584321
[TBL] [Abstract][Full Text] [Related]
10. An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk.
Yau C; Sninsky J; Kwok S; Wang A; Degnim A; Ingle JN; Gillett C; Tutt A; Waldman F; Moore D; Esserman L; Benz CC
Breast Cancer Res; 2013; 15(5):R103. PubMed ID: 24172169
[TBL] [Abstract][Full Text] [Related]
11. Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue.
Sinicropi D; Qu K; Collin F; Crager M; Liu ML; Pelham RJ; Pho M; Dei Rossi A; Jeong J; Scott A; Ambannavar R; Zheng C; Mena R; Esteban J; Stephans J; Morlan J; Baker J
PLoS One; 2012; 7(7):e40092. PubMed ID: 22808097
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.
Vukmirovic M; Herazo-Maya JD; Blackmon J; Skodric-Trifunovic V; Jovanovic D; Pavlovic S; Stojsic J; Zeljkovic V; Yan X; Homer R; Stefanovic B; Kaminski N
BMC Pulm Med; 2017 Jan; 17(1):15. PubMed ID: 28081703
[TBL] [Abstract][Full Text] [Related]
14. Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
Stricker TP; Morales La Madrid A; Chlenski A; Guerrero L; Salwen HR; Gosiengfiao Y; Perlman EJ; Furman W; Bahrami A; Shohet JM; Zage PE; Hicks MJ; Shimada H; Suganuma R; Park JR; So S; London WB; Pytel P; Maclean KH; Cohn SL
Mol Oncol; 2014 May; 8(3):669-78. PubMed ID: 24560446
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter.
Chen YJ; Huang CS; Phan NN; Lu TP; Liu CY; Huang CJ; Chiu JH; Tseng LM; Huang CC
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34387660
[TBL] [Abstract][Full Text] [Related]
16. Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
Nielsen T; Wallden B; Schaper C; Ferree S; Liu S; Gao D; Barry G; Dowidar N; Maysuria M; Storhoff J
BMC Cancer; 2014 Mar; 14():177. PubMed ID: 24625003
[TBL] [Abstract][Full Text] [Related]
17. Targeted Sequencing of Taiwanese Breast Cancer with Risk Stratification by the Concurrent Genes Signature: A Feasibility Study.
Huang CS; Liu CY; Lu TP; Huang CJ; Chiu JH; Tseng LM; Huang CC
J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34203389
[TBL] [Abstract][Full Text] [Related]
18. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
Sjöström M; Staaf J; Edén P; Wärnberg F; Bergh J; Malmström P; Fernö M; Niméus E; Fredriksson I
Breast Cancer Res; 2018 Jul; 20(1):64. PubMed ID: 29973242
[TBL] [Abstract][Full Text] [Related]
20. Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing.
Talla SB; Rempel E; Endris V; Jenzer M; Allgäuer M; Schwab C; Kazdal D; Stögbauer F; Volckmar AL; Kocsmar I; Neumann O; Schirmacher P; Zschäbitz S; Duensing S; Budczies J; Stenzinger A; Kirchner M
Genes Chromosomes Cancer; 2020 Jul; 59(7):406-416. PubMed ID: 32212351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
